Antifolate antimalarial resistance in southeast Africa: a population-based analysis

[1]  C. Drakeley,et al.  Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania , 2003, Antimicrobial Agents and Chemotherapy.

[2]  C. Plowe,et al.  Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. , 2002, The Journal of infectious diseases.

[3]  John C. Wootton,et al.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.

[4]  N. White,et al.  The evolution of drug-resistant malaria: the role of drug elimination half-life. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[5]  J. Kublin,et al.  Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. , 2002, The Journal of infectious diseases.

[6]  Li Li,et al.  PlasmoDB: the Plasmodium genome resource. An integrated database providing tools for accessing, analyzing and mapping expression and sequence data (both finished and unfinished) , 2002, Nucleic Acids Res..

[7]  B. Sharp,et al.  Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. , 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[8]  I. Adagu,et al.  Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  A. Saul,et al.  Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum , 2001, Parasitology.

[10]  E. Nduati,et al.  Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. , 2000, The Journal of infectious diseases.

[11]  A. Nzila,et al.  The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. , 2000, The American journal of tropical medicine and hygiene.

[12]  R. Snow,et al.  Averting a malaria disaster , 1999, The Lancet.

[13]  C. Plowe,et al.  More on 'the efficacy of antifolate antimalarial combinations in Africa'. , 1999, Parasitology today.

[14]  K. Marsh.  Malaria disaster in Africa , 1998, The Lancet.

[15]  J. E. Hyde,et al.  Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine‐resistant malaria , 1998, The EMBO journal.

[16]  J. Kublin,et al.  Molecular assays for surveillance of antifolate-resistant malaria , 1998, The Lancet.

[17]  M. Duraisingh,et al.  In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment. , 1998, The Journal of infectious diseases.

[18]  P. Sims,et al.  On ;the efficacy of antifolate antimalarial combinations in Africa'. , 1998, Parasitology today.

[19]  T. Triglia,et al.  Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  O. Doumbo,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. , 1997, The Journal of infectious diseases.

[21]  X. Su,et al.  Complex Polymorphisms in an ∼330 kDa Protein Are Linked to Chloroquine-Resistant P. falciparum in Southeast Asia and Africa , 1997, Cell.

[22]  J. E. Hyde,et al.  Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. , 1997, Molecular and biochemical parasitology.

[23]  X. Su,et al.  Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. , 1996, Genomics.

[24]  T. Wellems,et al.  Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Cowman,et al.  Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Wellems,et al.  Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Payne.  Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? , 1988, Parasitology today.

[28]  D. Hartl,et al.  Principles of population genetics , 1981 .

[29]  D. Clyde.  Malaria in Tanzania. , 1967 .

[30]  S. A. Jones.  Mass treatment with pyrimethamine; a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952-September 1953. , 1958, Transactions of the Royal Society of Tropical Medicine and Hygiene.